Status:
COMPLETED
MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients
Lead Sponsor:
Tanta University
Conditions:
Metabolic- Associated Fatty Liver Disease (MAFLD)
Eligibility:
All Genders
18+ years
Brief Summary
Metabolic-associated fatty liver disease (MAFLD), is a metabolic stress-induced liver injury characterized by diffuse hepatocyte macrovesicular fatty infiltration. The incidence of MAFLD is increasin...
Detailed Description
This study will be a cross-sectional study and will be carried out on 380 MAFLD patients attending to Tanta tropical medicine outpatient clinic, faculty of medicine. The start of the research will be ...
Eligibility Criteria
Inclusion
- Male or female patients older than 18 years.
- NAFLD Patients assessed by ultrasound, fibroscan.
Exclusion
- Patients aged \< 18 years
- pregnant women.
- Excess alcohol intake (more than 30 g in men and 20 g in women).
- Viral hepatitis.
- Autoimmune hepatitis
- secondary fatty liver (e.g., the use of systemic steroids or methotrexate).
- history of malignancy in the past 2 years.
- Unwilling to participate in our study.
Key Trial Info
Start Date :
March 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
382 Patients enrolled
Trial Details
Trial ID
NCT06492369
Start Date
March 15 2024
End Date
March 1 2025
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tropical medicine department, Tanta University Hospitals
Tanta, Gharbyea, Egypt, 31527